KLLN
KLLN (killin, p53 regulated DNA replication inhibitor) is a nuclear DNA-binding protein that inhibits DNA synthesis and links S phase arrest to apoptosis. It is encoded by an intronless gene and its expression is upregulated by the transcription factor p53. Browse Assay Genie's current range of KLLN research reagents below, or read on for the biology behind the target.
KLLN, also known as killin, is a DNA-binding protein involved in S phase checkpoint control coupled to apoptosis. It mediates p53/TP53-induced apoptosis and has the ability to inhibit DNA synthesis and to cause S phase arrest that is coupled to apoptosis. In this way the KLLN protein connects the p53 response to the control of DNA replication.
Killin shows affinity for both double-stranded and single-stranded DNA, consistent with its role as a DNA-binding protein. It is found in the nucleus. The KLLN gene is intronless, and its expression is upregulated by p53, placing it downstream of this transcription factor in the response that restrains DNA synthesis and promotes cell death.
The approved HGNC name is killin, p53 regulated DNA replication inhibitor, and an earlier name given to the gene was killin, p53-regulated DNA replication inhibitor. Because of its link to p53 signalling, replication control and apoptosis, KLLN is a useful subject for researchers studying how cells coordinate S phase checkpoints with cell death. Researchers working on the KLLN gene or on killin protein expression should consider the nuclear localisation of the protein when planning experiments.
KLLN expression is upregulated by p53, making it a relevant readout of p53-driven transcriptional responses and of p53-induced apoptosis.
Killin inhibits DNA synthesis and promotes S phase arrest, so it is studied in checkpoint mechanisms that restrain DNA replication.
The protein couples S phase arrest to apoptosis and mediates p53/TP53-induced apoptosis, supporting studies of replication-linked cell death.
Killin binds both double- and single-stranded DNA, offering a subject for work on nuclear DNA-binding proteins and replication regulation.
KLLN is a nuclear DNA-binding protein involved in S phase checkpoint control coupled to apoptosis. It mediates p53/TP53-induced apoptosis, can inhibit DNA synthesis and promotes S phase arrest coupled to apoptosis. It binds both double- and single-stranded DNA.
KLLN is the HGNC symbol for killin, p53 regulated DNA replication inhibitor. The protein is usually called killin, and the gene was previously named killin, p53-regulated DNA replication inhibitor. The UniProt entry lists the protein name as Killin.
Expression of KLLN is upregulated by the transcription factor p53. The killin protein then mediates p53/TP53-induced apoptosis, inhibiting DNA synthesis and coupling S phase arrest to cell death. Check the datasheet of any product for its validated reactivity.
p53 pathway proteins, cell cycle regulators and apoptosis markers that sit alongside KLLN in replication checkpoint research.
Gene and protein annotations from HGNC, NCBI Gene and UniProt B2CW77; product specifications from Assay Genie datasheets.